ArticleAmerican journal of preventive cardiology2025
Factors and outcomes associated with adherence to statins among patients with newly diagnosed cardiovascular disease.
Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Changes in LDL-C levels among primary health care patients with hypertension, coronary artery disease, and diabetes during a 36-month follow-up.Scandinavian journal of primary health care · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Statin use is proven to be effective in lowering low-density lipoprotein cholesterol (LDL-C) levels and reducing risk of recurrent myocardial infarction, stroke, and mortality in individuals with established cardiovascular disease (CVD). We used medication dispensed data (e.g., SureScripts), which has been integrated with the electronic health record (EHR) to examine the factors and outcomes associated with adherence to statins. Methods: This study is a secondary data analysis using longitudinal data between 1/1/2010-10/31/2021 ( Results: Of the 5155 patients with newly prescribed statins, a total of 3553 (68.9 %) were adherent, with insurance type, online patient portal use, race, age, statin intensity, and cardiologist visits emerging as significant predictors. Specifically, patients with PPO/FFS were less likely to fill statin prescriptions compared to those with HMO. Infrequent online patient portal use is associated with lower adherence. There is a disparity between patients race categories (Non-Hispanic Black (NHB) vs. Non-Hispanic White (NHW)) in filling the prescription and adhering to the filled prescription. Medication adherence is defined as proportion of days covered (PDC) of 80 % or greater. Adherence was positively associated with older age, high-intensity statins, and cardiologist visits. Having a visit with a cardiologist showed better adherence to the prescription and lowering of LDL values. Additionally, adhering to statins has shown a better outcome of lowering patients LDL values. Conclusions: The findings emphasize demographic and healthcare factors in medication adherence and LDL control, suggesting tailored interventions for diverse populations, addressing disparities in insurance type, race, and online portal use, and involving cardiologists in medication management for improved medication adherence and clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.